health benefits of glp-1 agonists Can one drug do it all? Reviewing the expanding clinical universe Discover the Game-Changing Benefits of
Description
Underreporting may exist due to voluntary submissions
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. New England Journal of Medicine
[DOI] [PubMed] [Google Scholar] 64.Krause GC, Lima KG, Dias HB, da Silva EFG, Haute GV, Basso BS, et al
The connection isnt clear-cut: one trial found 2.8% of semaglutide users developed gallbladder disorders vs
The New England Journal of Medicine, 391 (2), 109121
August 2012.
